
Tarek Nafee MD MMSc
@tarekomarnafee
❤️ Fellow @SLUCards | Former Clinical Trials Fellow @BidmcCvi PERFUSE Study Group | Aspiring IC & Clinical Trialist
ID: 921931956992045057
https://scholar.google.com/citations?hl=en&user=kqHVtr8AAAAJ 22-10-2017 02:51:22
1,1K Tweet
2,2K Followers
4,4K Following


12 states did not expand Medicaid under the #ACA Our JAMA Cardiology study led by Andrew Oseran, MD MBA provides a recent snapshot of uninsurance, care access, & #cardiovascular risk factor management for younger adults w/ low income by Medicaid expansion status /1 jamanetwork.com/journals/jamac…


The Clinical Trials Fellowship at PERFUSE with C. Michael Gibson MD was a period of immense personal & professional growth for me. I highly recommend this immersive, once in a lifetime experience with a giant in the field and an inspirational leader. If you are considering - Apply!


Congrats to our most recent Humanistic Healer award winners - M. Khurram Afzal. "Dr. Afzal's demeanor, professionalism, & willingness to help our team was exceptional & he should be recognized for his great work!” Khurram Afzal MD


Love the camaraderie of our fellows. This is what makes us proud 💪🏼 As we warm heartedly welcomed our new fellows Willy Frick Jibran Mirza Tarek Nafee MD MMSc and Somshukla Ghosh, we will soon welcome applications from across the country for #Match2023 American College of Cardiology Missouri ACC

7th annual Cardiology Fellows Boot Camp - next two Saturdays! Look at this all star lineup! Registration QR in the photo Cheryl Sydney @ivan_chevere New York Chapter, ACC Sahil Khera @ajaykirtane Carlos L. Alviar MD, FACC Suzanne J. Baron MD MSc Babar Basir Luigi Di Biase Anu Lala-Trindade Felix Yang, MD, FACC, FHRS


Differentiating VT Form SVT on #ECG can be challenging! We developed a user friendly algorithm based on clinical info and 2 leads (II,aVR). In a clinical validation residents and fellows are as proficient as #EPeeps JACC Journals tinyurl.com/44bfs5kx


1/x Mini-Tweetorial on External Validity vs. Competing Risk. Based on an ongoing discussion with John Mandrola, MD , Alex Sandhu , Gregg Fonarow MD, @mikejohansenmd and others, I have put together this mini-tweetorial on how to think about external validity of trials vs. competing risks.

🧵What does the left atrial appendage do? Is it just a nidus for thrombus? A brief review of proposed & proven functions of the LAA👇 #CardioTwitter #EPeeps #MedEd @drpaulfriedman Chet Rihal



Our fellows had a very engaging session with Dr Gopinathannair Rakesh Gopinath and Dr Philip Mar learning 🫀 anatomy and it’s implications with interventional, structural and EP procedures. Thank you Abbott Cardiovascular for arranging this. #KCHRI #ACCFIT #EPeeps


Echocardiographic signs to screen for PH, a thread🧵 Mohammed Megri. MD Huzaifah ATS PC Assembly Zonair Khan Gustavo Heresi, MD, MS Bhavna Sharma, MD, FCCP Soban Umar, MD, PhD, FAHA, ATSF 🫁🫀 The Pulmonary Vascular Research Institute Huzaifah Amjad Kanj @echonous Sebastien « Seb » Bonnet Stanford Wall Center Einstein PCCM

We're probably all meant to live with an LDL around 30 mg/dl (further evidence) observational data from FOURIER trial Achieved LDL <20 mg/dl (red line) *lowest event rate (L) *lowest all-cause mortality (R) *no safety signals (R) Analysis from @prakritigaba TIMI Study Group




